DELVET HALOTHANE

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

Buy It Now

Active ingredient:
HALOTHANE
Available from:
PIRAMAL ENTERPRISES LIMITED
INN (International Name):
halothane(99.99%)
Pharmaceutical form:
MISC. AURAL, OPHTHALMIC, ORO/NASO PHARYNGEAL
Composition:
HALOTHANE ANAESTHETIC Active 99.99 %
Units in package:
250mL
Class:
VM - Veterinary Medicine
Manufactured by:
PIRAMAL ENTERPRISES
Therapeutic group:
CALF | CATTLE | HORSE | HORSE FOAL | PIG - HEAVIER THAN 30 KG LIVEWEIGHT | PIG - LESS THAN 30 KG LIVEWEIGHT | SHEEP | SMALL ANIM
Therapeutic area:
ANAESTHETICS/ANALGESICS
Therapeutic indications:
ANAESTHETIC - LOCAL/GENERAL | GENERAL ANAESTHETIC | IMMOBILISER | LOCAL ANAESTHETIC | PREMEDICATION | SEDATIVE | TRANQUILLISER | TRAVEL SICKNESS
Product summary:
Poison schedule: 4; Withholding period: WHP:N/A; Host/pest details: CALF: [ANAESTHETIC - LOCAL/GENERAL]; CATTLE: [ANAESTHETIC - LOCAL/GENERAL]; HORSE: [ANAESTHETIC - LOCAL/GENERAL]; HORSE FOAL: [ANAESTHETIC - LOCAL/GENERAL]; PIG - HEAVIER THAN 30 KG LIVEWEIGHT: [ANAESTHETIC - LOCAL/GENERAL]; PIG - LESS THAN 30 KG LIVEWEIGHT: [ANAESTHETIC - LOCAL/GENERAL]; SHEEP: [ANAESTHETIC - LOCAL/GENERAL]; SMALL ANIMALS: [ANAESTHETIC - LOCAL/GENERAL]; Poison schedule: 4; Withholding period: ; Host/pest details: CALF: [ANAESTHETIC - LOCAL/GENERAL]; CATTLE: [ANAESTHETIC - LOCAL/GENERAL]; HORSE: [ANAESTHETIC - LOCAL/GENERAL]; HORSE FOAL: [ANAESTHETIC - LOCAL/GENERAL]; PIG - HEAVIER THAN 30 KG LIVEWEIGHT: [ANAESTHETIC - LOCAL/GENERAL]; PIG - LESS THAN 30 KG LIVEWEIGHT: [ANAESTHETIC - LOCAL/GENERAL]; SHEEP: [ANAESTHETIC - LOCAL/GENERAL]; SMALL ANIMALS: [ANAESTHETIC - LOCAL/GENERAL]; A volatile anaesthetic for domestic animals.
Authorization status:
Registered
Authorization number:
53437
Authorization date:
2020-07-01

DNH 22018

DELVET

HALOTHANE

Page 2 (inside front)

size: 115 x 53

Page 3

size: 112 x 53

Page 4

size: 112 x 53

Page 5

size: 111 x 53

Page 6

size: 111 x 53

Page 7

size: 112 x 53

Page 8

size: 112 x 53

Page 1 (front)

size: 115 x 53

14.5 x 5.3

L x H

14-12-2007

GA/7661/S

SIZE

in Cms.

SIZE

Scaling

100%

Pantone Black

leaflet hinge

leaflet peel

and reseal area

53mm

21mm

21mm

leaflet position

115mm

OPEN

HERE

Dark blue shows

Varnish area

base label 145 x 53 mm

5 mm

5 mm

LOT NO:

MNF:

EXP. DATE:

HALOTHANE

DNH 22018

Code : AP/DRUGS/220/96

PRESCRIPTION ANIMAL REMEDY

KEEP OUT OF REACH OF CHILDREN

FOR ANIMAL TREATMENT ONLY

Halothane 99,99%

A volatile anaesthetic for domestic animals.

READ LABEL BEFORE USING THIS PRODUCT

250mL

DELVET PTY LTD

B4, 26 Powers Rd

Seven Hills NSW 2147

AUSTRALIA

Phone: (02) 9624 7884.

APVMA 53437/250ML/1107

KEEP WELL CLOSED

First Aid: If poisoning occurs contact

a doctor or Poisons Information Centre.

Phone 131126.

Store below 25°C (air conditioning)

in tightly closed, original container until

immediately prior to use. Protect from light.

HALOTHANE

DNH 22018

Code : AP/DRUGS/220/96

PRESCRIPTION ANIMAL REMEDY

KEEP OUT OF REACH OF CHILDREN

FOR ANIMAL TREATMENT ONLY

Halothane 99,99%

A volatile anaesthetic for domestic animals.

READ LABEL BEFORE USING THIS PRODUCT

250mL

DELVET PTY LTD

B4, 26 Powers Rd

Seven Hills NSW 2147

AUSTRALIA

Phone: (02) 9624 7884.

APVMA 53437/250ML/1107

KEEP WELL CLOSED

First Aid: If poisoning occurs contact

a doctor or Poisons Information Centre.

Phone 131126.

Store below 25°C (air conditioning)

in tightly closed, original container until

immediately prior to use. Protect from light.

Delvet Halothane, which contains

0.01% w/w thymol as a stabilising

agent, is non-flammable and non-

explosive when mixed with oxygen.

It is an almost colourless, volatile

liquid

with

distinctive

pleasant

odour.

INDICATIONS

inhalation

anaesthetic

domestic

farm

animals

birds.

also

suitable

anaesthesia in a wide range of non-

domesticated

species,

especially

birds and reptiles.

DIRECTIONS FOR USE

DOSAGE AND ADMINISTRATION:

Halothane may be given by open,

closed

semi-closed

circuit

methods and is usually volatilised in

oxygen or a mixture of nitrous oxide

and oxygen. It is important to note

that

vapour

concentration

obtained from a vaporiser is equal

to the inspired concentration only

when a draw-over vaporiser is used

in a non-rebreathing circuit or in the

inspiratory limb of a circle system.

Small animals and pigs up to 30kg

body weight.

Induction:

Anaesthesia

induced by the inhalation of 2-4%

halothane vapour from a face-mask.

In large and excitable subjects, a

short-acting

barbiturate

such

thiopentone sodium may be used to

produce

unconsciousness

before

administering halothane.

Induction may also be facilitated by

premedication with a phenothiazine

derivative such as chlorpromazine

hydrochloride.

Maintenance:

inspired

concentration of halothane should

be reduced to 0.5-2% once surgical

anaesthesia has been obtained and

maximum

economy

closed

circuit methods may be used with

oxygen flow rates of 50-300 mL per

minute.

When the vaporiser is incorporated

in the breathing circuit, great care

should

taken

performing

intermittent

positive

pressure

ventilation

lungs

this

procedure

temporarily

produce

high

concentrations

halothane vapour.

In emergency situations halothane

may be given by open methods

utilising improvised face-masks.

Foals, calves, sheep and larger

pigs (over 30kg bodyweight)

Induction: It is possible to induce

anaesthesia

administration

halothane

standing

animal

using a Cox mask in a manner

similar to that traditionally used for

chloroform, although this method is

normally

confined

foals

calves.

Foals, calves and sheep up to 25-30

easily

restrained

induction of anaesthesia by 2-4%

halothane vapour. In larger animals

a barbiturate such as thiopentone

sodium may be given intravenously

to produce loss of consciousness

before

exposure

halothane

vapour.

Maintenance: Provided due care is

taken

maintain

free

airway,

maintenance

anaesthesia

with

0.5-2% halothane vapour presents

no special problems.

Horses and cattle

Induction:

In adult subjects it is

more usual to employ a barbiturate

such

thiopentone

sodium

p r o d u c e

u n c o n s c i o u s n e s s .

Concentrations of 5-8% halothane

may then be fed into the breathing

circuit to complete the induction of

surgical

anaesthesia

5-10

minutes.

Maintenance: Anaesthesia may be

maintained by the administration of

0.8-2% halothane vapour. To give

this concentration to the animal it is

usually necessary to deliver 1.5-5%

from any vaporiser placed outside

the breathing circuit at least for the

first hour.

maximum

economy,

closed

circuit administration with oxygen

flow rates just sufficient to prevent

emptying of the re-breathing bag

should be used. A flow rate of 1.5-2

litres per minute is normally needed

to achieve this.

RECOVERY

Recovery from halothane is usually

rapid and uneventful but may be

slower if premedication has been

given or if anaesthesia has been

induced with a barbiturate.

CONTRA-INDICATIONS

ADVERSE REACTIONS

Delvet Halothane is contraindicated

for use in animals with a known

hypersensitivity to halothane or a

known

sensitivity

malignant

hyperthermia.

Should

respiratory

arrest occur due to the use of too

h i g h

c o n c e n t r a t i o n ,

t h e

concentration should be promptly

reduced by flushing the breathing

circuit with pure oxygen and artificial

ventilation of the lungs immediately

commenced. Artificial ventilation,

with

periodic

flushing

breathing

circuit,

should

continued

until

natural

breathing

recommences.

PRECAUTIONS

Halothane should be avoided or

used with caution in patients with

raised

cerebrospinal

fluid

pressure,

space-occupying

intracranial

lesions,

cardiac

d y s f u n c t i o n ,

e s p e c i a l l y

cardiomyopathy or dysrhythmias,

hepatic disease or susceptibility

to malignant hyperthermia.

Halothane potentiates the action

of gallamine and d-tubocurarine

sensitises

heart

catecholamines. Smaller doses

of gallamine and d-tubocurarine

should, therefore, be used and

infiltration

tissues

with

adrenaline

should

avoided

where possible.

To

prevent

overdosage

when

intermittent

positive

pressure

ventilation of the lungs is being

used

conjunction

with

relaxants,

halothane

should

given

from

accurately

calibrated

vaporiser

non-

r e b r e a t h i n g

c i r c u i t ,

alternatively,

end-tidal

concentration

halothane

s h o u l d

m o n i t o r e d

continuously

with

halothane

meter.

Halothane

induce

liver

damage. This is an idiosyncratic

response very occasionally seen

after repeated exposure.

A D D I T I O N A L

S A F E T Y

INFORMATION

Do not breathe vapour.

Avoid contact by mouth.

Use

with

efficient

scavenging

equipment.

Ensure that the operating room

has an adequate active extraction

system.

Care

should

taken

when

dispensing

halothane,

with

immediate removal of spillage.

Wash any splashes from skin and

eyes immediately.

Induction/Recovery areas should

be well ventilated.

All

scavenging/extraction

systems

must

adequately

maintained

anaesthetic

equipment regularly checked for

leaks.

R e p e a t e d

e x p o s u r e

halogenated

anaesthetics

been

linked

increased

miscarriages

personnel

operating theatres.

When exposed to a naked flame,

halothane

decompose

liberate

bromine.

Whilst

this

should not present any hazard,

adequate room ventilation should

ensured

during

halothane

administration,

both

this

reason and to protect operating

room personnel from prolonged

exposure to low concentrations.

FURTHER INFORMATION

1. In

presence

moisture,

halothane will cause corrosion of

some

metals.

Vaporisers,

valve

caps and gaskets in closed circuit

apparatus should be inspected at

regular

intervals

evidence

corrosion.

2. Halothane residues in vaporisers

may become discoloured due to

concentration

thymol.

Grossly

discoloured

material

should be discarded.

WITHHOLDING

PERIOD:

Withholding

Period

been

established

this

product.

Prescribing

veterinarians

should

ensure

that

appropriate

interval

exists

between treatment and slaughter for human

consumption.

TRADE ADVICE

EXPORT SLAUGHTER INTERVAL (ESI): This

product does not have an ESI established. For

advice on the ESI, contact the distributor on 02

9624 7884 before using this product.

FIRST AID:

If poisoning occurs contact a doctor or Poisons

Information Centre. Phone 131126.

DISPOSAL

Dispose of empty container by wrapping with

paper and putting in garbage.

Manufactured by:Nicholas Piramal India Limited

N.H. 9, Digwal Village, Kohir Mandal,

Kohir Cross Road,

Medak Dist. 502 321.Andhra Pradesh, India.

File name : 53437_43323_250ML_Label_MPL_V02.pdf

Date PDF prepared : 14-12-2007

Label dimensions (in cms) : 14.5 x 5.3 cms

The scale when the PDF is printed on A4 paper : 60%

The scale when the PDF is printed on A3 paper : 85%

Pantone 293 C

Pantone 136 C

APPROVED

LABEL

Info

pest

Verified

ProductName: Delvet Halothane

Page: 1 of 5

This revision issued: October, 2008

MATERIAL SAFETY DATASHEET

Issued by:Delvet PtyLtd Phone: +61 2 9624 8844

Section 1 - Identification ofChemical Product and Company

Delvet PtyLtd Phone: +61 2 9624 8844

26 Powers Rd Fax: +61 2 9624 1544

Seven Hill, NSW 2147

Substance: Halogenatedethane (contains fluorine, chlorineand bromine).

Trade Name: Delvet Halothane

Other Names:2-bromo-2-chloro-1,1,1-trifluoroethane

APVMA Code:53437

Product Use: Anaesthetic for domestic animals.

Creation Date: October, 2008

This revision issued: October, 2008

Section 2 - Hazards Identification

Statement of Hazardous Nature

This productis classifiedas:Xi, Irritating. Hazardousaccording to the criteriaof ASCC.

Not a Dangerous Good according to theAustralian DangerousGoods (ADG) Code.

Risk Phrases:R36, R61.Irritating to eyes. May cause harm to the unborn child.

SafetyPhrases:S23, S25, S36, S45,S24/25. Do not breathe vapours. Avoid contact with eyes. Wearsuitable

protective clothing. In caseof accident orif you feel unwell, contact a doctor or Poisons Information Centre

immediately (show this MSDS where possible). Avoidcontact with skin and eyes.

SUSDP Classification:S4

ADG Classification:Class 9(Air transport only)

UN Number:3334, Aviation RegulatedLiquid, N.O.S. (Air transport only)

EmergencyOverview

Physical Description & Colour: Clear, colourless liquid.

Odour:No data.

Major Health Hazards:may cause harm to unborn children, eye irritant. Thisis a physiologically active product

and so contact should beminimised, especially if theuseris takinga form of medication, as interactionscan

sometimes give unexpected and undesired results.

Potential Health Effects

Inhalation:

Short TermExposure:Available data indicates that this productmay be harmful if inhaled. Exposure may have a

narcotic effect. Can causedizziness, confusion, drowsiness and unconsciousness. May cause a drop in blood

pressure.

Long Term Exposure:No data for health effectsassociatedwith long term inhalation.

Skin Contact:

Short TermExposure:Available data indicates that this productmay be harmful if absorbed through the skin.

Product is believed to be mildly irritating, but is unlikelyto cause anything more than mild transient discomfort.

Long Term Exposure:No data for health effectsassociatedwith long term skin exposure.

Eye Contact:

Short TermExposure:This product isan eye irritant. Symptoms may includestingingand reddening of eyes and

watering which may become copious. Other symptomsmayalsobecome evident. Ifexposure isbrief, symptoms

should disappear once exposure hasceased. However, lengthy exposure ordelayed treatment may causepermanent

damage.

Long Term Exposure:No data for health effectsassociatedwith long term eye exposure.

Ingestion:

ProductName: Delvet Halothane

Page: 2 of 5

This revision issued: October, 2008

MATERIAL SAFETY DATASHEET

Issued by:Delvet PtyLtd Phone: +61 2 9624 8844

Short TermExposure:Significant oral exposure isconsideredto beunlikely. May be harmful if swallowed. This

product is anoral irritant. Symptoms may include burning sensation and reddening of skin in mouth and throat. Other

symptomsmay also become evident, but all should disappear once exposurehasceased.

Long Term Exposure:No data for health effectsassociatedwith long term ingestion.

Carcinogen Status:

ASCC:No significant ingredient isclassified ascarcinogenic by ASCC.

NTP:No significant ingredient is classified as carcinogenic by NTP.

IARC:No significant ingredient isclassified ascarcinogenic by IARC.

Section 3 - Composition/Information on Ingredients

Ingredients CAS No Conc,% TWA (mg/m 3 ) STEL (mg/m 3 )

Halothane151-67-7 99.99 4.1 not set

thymol 89-83-8 0.01 not set not set

The ASCCTWAexposurevalue is the averageairborne concentration of a particularsubstance whencalculated over a normal 8 hour workingday

for a 5 dayworkingweek. The STEL (ShortTermExposure Limit) isan exposure value thatmaybe equalled (but should not be exceeded) forno

longer than 15 minutes and should not be repeated more than4 times per day. There should be at least 60 minutes between successive exposures

at the STEL.Theterm "peak "is used when theTWA limit, becauseof the rapid action of the substance, should never be exceeded, even briefly.

Section 4 - First Aid Measures

General Information:

You should call The Poisons Information Centre if youfeel that you may have been poisoned, burned orirritated by

this product. The number is13 1126 fromanywhere in Australia (0800 764 766 in New Zealand) and is available at all

times.Have thisMSDS withyou when you call.

Inhalation:If inhaled, move to fresh air. If person isnot breathing,apply artificial respiration. If breathing isdifficult,

oxygen wouldbe helpful. Ifin doubt, contact a Poisons InformationCentre or a doctor.

Skin Contact:Wash gently and thoroughly with water (use non-abrasive soapif necessary) for 10 minutes or until

chemical isremoved. If irritation persists, repeat flushing and obtainmedical advice.

Eye Contact:Immediately flush the contaminated eye(s) with lukewarm, gentlyflowing water for 20 minutes oruntil

the product is removed, while holding the eyelid(s) open.Take carenot to rinsecontaminatedwater into the

unaffectedeye or onto theface. Obtainmedical attention immediately. Take special care if exposed personis wearing

contact lenses.

Ingestion:If swallowed, doNOT induce vomiting. Wash mouth with water and contact a Poisons Information

Centre, or call a doctor.

Section 5 - Fire Fighting Measures

Fire and Explosion Hazards: Thereis no risk ofan explosionfrom this product under normal circumstances if it is

involved in a fire.

Fire decomposition products from this product are likely to be toxicand corrosiveif inhaled. Take appropriate

protective measures.

Extinguishing Media:Not Combustible. Use extinguishing media suited to burning materials.

Fire Fighting:If a significant quantity of this productisinvolved ina fire, call thefire brigade.

Flash point: Doesnot burn.

Upper FlammabilityLimit: Doesnot burn.

Lower FlammabilityLimit: Doesnot burn.

Autoignitiontemperature: Not applicable - does not burn.

Flammability Class: Doesnot burn.

Section 6 - Accidental Release Measures

Accidental release:Thisproduct is sold in small packages, andthe accidental release fromone of these is not

usually a cause forconcern. For minor spills, clean up, rinsing to sewer and put empty container in garbage. Although

no special protective clothing is normallynecessary becauseof occasional minor contactwith this product, it is good

practice to wear impermeable gloveswhen handlingchemicalproducts. In the event of a major spill, prevent spillage

from enteringdrainsorwater courses and call emergency services.

ProductName: Delvet Halothane

Page: 3 of 5

This revision issued: October, 2008

MATERIAL SAFETY DATASHEET

Issued by:Delvet PtyLtd Phone: +61 2 9624 8844

If there is a significant chance that vapours are likelyto build up inthe cleanup area, werecommend that you use a

respirator. It should befitted with a type AX cartridge, suitable for low boiling pointorganic compounds. See

manufacturer's specifications for detailed specifications.

Section 7 - Handling and Storage

Handling:Keep exposureto this product to a minimum, and minimise the quantities kept in work areas. Check

Section 8 of this MSDS for details of personal protectivemeasures,and make sure that those measures arefollowed.

The measuresdetailed below under "Storage" shouldbe followed during handling in order tominimise risks to

personsusing the productin the workplace. Also, avoidcontact or contamination of productwith incompatible

materials listed in Section 10.

Storage:This product is aScheduled Poison. Observe all relevantregulationsregardingsale, transport and storage

of this schedule of poison.Store packagesof this product in a cool place, below25°C. Protect from sunlight. Make

sure that containers of thisproduct arekept tightly closed. Makesure that theproduct does not come intocontact with

substanceslisted under "Incompatibilities" in Section10.Check packaging - there may be furtherstorageinstructions

on the label.

Section 8 - Exposure Controlsand Personal Protection

The followingAustralian Standards will provide general advice regarding safety clothing and equipment:

Respiratory equipment:AS/NZS 1715, Protective Gloves:AS 2161, Industrial Clothing:AS2919, Industrial Eye

Protection:AS1336andAS/NZS 1337, Occupational ProtectiveFootwear:AS/NZS2210.

ASCCExposure Limits TWA (mg/m 3

) STEL (mg/m 3

)

Halothane4.1 not set

No special equipment is usually neededwhenoccasionallyhandlingsmall quantities. The following instructions are

for bulk handling or where regularexposure in an occupational setting occurswithout propercontainment systems.

Ventilation:This productshould only be used wherethere isventilation that is adequate to keep exposurebelow

the TWA levels. If necessary, use an adequate extraction system.

Eye Protection:Protective glasses or gogglesshould be wornwhenthis product is beingused. Failure to protect

your eyes may cause themharm. Emergency eye wash facilities arealso recommended in an area close to where

this product is beingused.

Skin Protection:You should avoidcontact even with mild skin irritants. Therefore you should wearsuitable

impervious elbow-length gloves and facial protectionwhenhandling this product. See below for suitable material

types.

Protective Material Types:We suggest that protective clothingbe made from the following materials:rubber.

Respirator:Usually, no respiratoris necessary whenusing this product. However, if you have any doubts consult

the AustralianStandard mentioned above.

Eyebaths oreyewashstations and safety deluge showersshould be provided near to where this product is being

used.

Section 9 - Physical and Chemical Properties:

Physical Description & colour:Clear, colourless liquid.

Odour:No data.

Boiling Point: Approx 50°Cat 100kPa

Freezing/Melting Point: No specific data. Liquid at normal temperatures.

Volatiles: Completely volatile at 100°C.

Vapour Pressure: 32.20 kPa at20°C

Vapour Density:No data.

Specific Gravity: 1.868 at 20°C

Water Solubility: Slightly soluble (<1% at 25°C).

pH:No data.

Volatility:No data.

Odour Threshold:No data.

Evaporation Rate:No data.

Coeff Oil/water Distribution: No data

Autoignition temp: Not applicable - does not burn.

Refractive index: 1.369 at 0°C

ProductName: Delvet Halothane

Page: 4 of 5

This revision issued: October, 2008

MATERIAL SAFETY DATASHEET

Issued by:Delvet PtyLtd Phone: +61 2 9624 8844

Section 10 - Stabilityand Reactivity

Reactivity:No significantdecomposition products. May decomposeon exposure to light, so keep in darkened

containers and avoid exposure to sunlight. Dissolvesrubber and many plastics.

Conditions to Avoid:This product should bekept in a cool place,preferably below25°C. Keep containers tightly

closed. Keepcontainers and surroundingareas wellventilated. Protect this product from light.

Incompatibilities:strongoxidising agents, zinc, tin, aluminium and their alloys.

Fire Decomposition:Carbondioxide,and if combustion isincomplete, carbonmonoxide and smoke. Hydrogen

chloride gas,other compounds of chlorine. Hydrogen fluoride gas and othercompounds of fluorine.Water,bromine

compounds.Carbon monoxide poisoning produces headache,weakness, nausea, dizziness, confusion, dimness of

vision, disturbance of judgment, and unconsciousness followed by coma and death.

Polymerisation:This product will not undergo polymerisation reactions.

Section 11 - Toxicological Information

Local Effects:

Target Organs: This productmay attackcentral nervous system, heart, kidneys, liver.

Classification of Hazardous Ingredients

IngredientRisk Phrases

No ingredientmentioned inthe HSIS Database is present in this product at hazardous concentrations.

Oral, Guinea Pig = 6000mg/kg

Section 12 - Ecological Information

Insufficient data to be sureof status.

Section 13 - Disposal Considerations

Disposal:Dispose of small quantities and empty containersby wrapping withpaper and putting with domestic

garbage. For largerquantities, if recycling or reclaimingis not possible, use acommercial waste disposalservice.

Section 14 - Transport Information

ADG Code:This productis not classified as aDangerousGoodwhen carriedby road orrailin Australia.No special

transport conditions are necessaryunless required by other regulations.

However, this is an Aviation Regulated Liquid, NOS. When carried byair, the following apply:

ADG Code:3334, Aviation RegulatedLiquid, N.O.S.

Hazchem Code:No Hazchemcodespecified.

Special Provisions:106, 274, 276

Dangerous Goods Class:9, Miscellaneous Dangerous Goods

Packaging Group:No packing group specified.

Packaging Method:No packaging methods specified.

Section 15 - RegulatoryInformation

AICS:All of the significant ingredients inthis formulation arecompliant with NICNAS regulations.

The followingingredient: Halothane, is mentioned in the SUSDP.

Section 16 - Other Information

This MSDS contains onlysafety-related information. For other data see product literature.

Acronyms:

ADG Code Australian Code for the Transport of Dangerous Goods by Road and Rail (7 th edition)

AICS Australian Inventory of Chemical Substances

ASCC Office of the Australian Safety and CompensationCouncil

CAS number Chemical Abstracts Service Registry Number

ProductName: Delvet Halothane

Page: 5 of 5

This revision issued: October, 2008

MATERIAL SAFETY DATASHEET

Issued by:Delvet PtyLtd Phone: +61 2 9624 8844

HazchemCode Emergency action code ofnumbers andlettersthat provide information to emergency

servicesespecially firefighters

IARC International Agency forResearch onCancer

NOS Not otherwisespecified

NTP National Toxicology Program (USA)

R-PhraseRisk Phrase

SUSDP Standard for the Uniform Scheduling ofDrugs & Poisons

UN NumberUnited Nations Number

THIS MSDS SUMMARISES OUR BEST KNOWLEDGEOFTHEHEALTHAND SAFETYHAZARD INFORMATIONOFTHE PRODUCT AND

HOW TOSAFELYHANDLE ANDUSE THE PRODUCT INTHE WORKPLACE.EACH USER MUSTREVIEW THIS MSDS IN THECONTEXTOF

HOW THE PRODUCT WILLBE HANDLEDANDUSED IN THE WORKPLACE.

IF CLARIFICATIONORFURTHER INFORMATION IS NEEDEDTOENSURETHATAN APPROPRIATE RISK ASSESSMENT CANBE MADE,

THE USER SHOULD CONTACTTHIS COMPANY SOWE CAN ATTEMPT TOOBTAIN ADDITIONAL INFORMATION FROMOUR SUPPLIERS

OURRESPONSIBILITYFOR PRODUCTS SOLDIS SUBJECT TO OURSTANDARD TERMS ANDCONDITIONS, ACOPYOFWHICH IS SENT

TOOUR CUSTOMERS AND IS ALSOAVAILABLEONREQUEST.

Please read all labels carefully before using product.

This MSDS isprepared in accord with the ASCCdocument “National Code of Practice for the Preparation

of Material Safety DataSheets” 2nd Edition [NOHSC:2011(2003)]

Copyright ©Kilford & Kilford Pty Ltd, October, 2008.

http://www.kilford.com.au/ Phone (02)9251 4532

Similar products

Search alerts related to this product

View documents history

Share this information